• Aucun résultat trouvé

Article pp.207-210 du Vol.31 n°155 (2005)

N/A
N/A
Protected

Academic year: 2022

Partager "Article pp.207-210 du Vol.31 n°155 (2005)"

Copied!
4
0
0

Texte intégral

(1)

1 Editorial

Jean-Marie Doublet 5 Contributors to this issue

9 RFG-AIMS: Towards a matured collaboration

Tugrul Atamer, Rodolphe Durand, Emmanuelle Reynaud

13 Innovation development

Tugrul Atamer, Rodolphe Durand, Emmanuelle Reynaud

23 R&D performance. The case of the French biotechnologies Olga Bruyaka

The present article suggests that the extent of scientific research and the links between firms are performance factors of the R&D of biotechnology enterprises. The results show that the specialisation in the abilities in biotechnology research have a positive and relevant impact over the R&D performance of enterprises working in this field. However, the results of our study do not confirm this effect in the case of collaboration between small biotechnology firms and major drug companies.

37 Decisive factors for the survival and the growth of the TIC start-ups Frank Lasch, Frédéric Le Roy, Saïd Yami

The present research in focussed on the study of the decisive factors on the survival and the growth of TIC start-ups. Based upon previous researches, hypothesis is drawn that three factors influence the survival and the growth of these enterprises: the human capital of the founder, the preparation to the founding and the structural features at the starting stage of the enterprise. This hypothesis is tested over 498 firms. The results obtained show that the human capital and the undertaker’s experience have a rather weak impact over the success of the TIC start-up. In the same way, the intensity of the formation does not represent generally a key-factor of success. On the contrary, organisation characteristics (amount of the invested capital or the customers’ structure) are strongly linked to the success of these start-up.

S U M M A R Y

issue 155 March – April 2005

INNOVATION DEVELOPMENT

Guest Editors : Tugrul Atamer, Rodolphe Durand, Emmanuelle Reynaud

13/Summary/155 4/05/05 14:55 Page 207

Cet article des Editions Lavoisier est disponible en acces libre et gratuit sur archives-rfg.revuesonline.com

(2)

57 Innovation strategy, competition and performance of new products Jean-Philippe Muller

The development of innovation products which comply with the consumer’s expectations, represent most often a vital activity for the growth of enterprises.

This research which concerns 161 products shows that the success of the launches depends upon the competition reaction. The results suggest that this competition reaction can be favourably oriented by the innovation strategy implemented.

75 Rupturing strategy and SME: the impossible replicative action Régis Dumoulin, Éric Simon

The rupturing strategies have been surveyed only for some major enterprises.

The aim of the present article shows that through a thorough survey of one case, theses strategies could be applied to innovative SME. However, the reproduction of such strategies are questionable when the structure resources are limited. Following a presentation of the rupturing strategy concept linked to the resources approach, the authors analyse the transposition of the concept and its limits when applied to small enterprises.

97 Values of the strategic innovation for the market leaders Pierre Roy

In a ludic competition figure of speech, the final aim of the strategy lies in knocking over the existing rules of the game in order to substitute a new game the operation conditions of which are mastered by the upsetter alone. The present research analyses the operation from the point of view of the market leaders, through the case of the multiplexes in the movies halls. The results confirm that it represents a powerful level for the consolidation of a sectorial sovereignty.

117 Difference between “big pharmas” and “biotechs”: the patents interpretation

Yves Bonhomme, Pascal Corbel, Jihane Sebai

The present article puts forward a comparison between major drug laboratories and biotechnology enterprises based upon an original method: the study of patent quotations. It aims at a better understanding the potential and the limits of this method and at a deepening of our investigations concerning the complementarity of theses two types of enterprises.

135 Propagation of a change inside major organisations Alain Vas

Most of the major enterprises evolve today in rapid mutation environments.

This established fact urges the managers to survey the levers amenable to 208 Revue française de gestion

13/Summary/155 10/05/05 10:40 Page 208

Cet article des Editions Lavoisier est disponible en acces libre et gratuit sur archives-rfg.revuesonline.com

(3)

accelerate or brake the deployment speed of a change inside their enterprise. At the light of a study carried out inside a European telecommunication operator, the author presents seven factors which can influence the propagation speed of a change inside major organisations. The analysis of these factors discloses contradictory effects in course of implementation.

153 The Logics of development of biotechnology enterprises Anne-Laure Saives, Mehran Ebrahimi, Robert H. Desmarteau, Catherine Garnier

This empirical study based upon 110 interviews carried out inside biotechnology enterprises sets up an analysis concerning the couple knowledge creativeness/ruling logics in the firms of high technology. It results in featuring three development modes: “pre-entrepreneurship”, “entrepreneurship” and

“managerial” in biotechnology enterprises the development of which would be outstanded by two ruptures: a teleological one and a challenge toward creativity.

173 Current exploration and driving of the research. The case of an enterprise specialised chemical products

Lise Gastaldi, Christophe Midler

The tremendous development of the innovation strategies leads to a thorough examination of the driving of the research function. How to organise dual exploration of potential markets and of technical fields? This question is examined in the present article through the example of a special chemical products enterprise. The longitudinal analysis shows a transition between three models: a “self driving”, of the research (between 1960-1975), a

“coupling and dependency” situation with respect to the business units (between 1975 and 1995) and an original model of “strategic interdependence” henceforth.

191 Organisation required for the valorisation of invention patents.

The case of Air Liquide

Cécile Ayerbe, Liliana Mitkova

The management of patents must stand aside from a purely legal approach. The aim of which is to impose the compliance with the monopolistic rights and to shift to a strategic logic according to which the patent is managed as a fundamental resource which generates a competitive advantage. Complying with this perspective, the management of the protected invention considered as tools and organisation modes appears as a key-stake for the enterprises. The present article aims to giving actually a conspicuous dimension to the Summary 209 13/Summary/155 12/05/05 12:51 Page 209

Cet article des Editions Lavoisier est disponible en acces libre et gratuit sur archives-rfg.revuesonline.com

(4)

organisation of the management of the industrial property and to studying the links between the strategic and organisation strakes of the patent management.

It stands on the authority of the case of Air Liquide.

207 Summary

211 Instructions for authors

210 Revue française de gestion

13/Summary/155 12/05/05 12:51 Page 210

Cet article des Editions Lavoisier est disponible en acces libre et gratuit sur archives-rfg.revuesonline.com

Références

Documents relatifs

La configuration dispersée des activités de R&D pose un redoutable problème de coordination aux entreprises multinationales dans le proces- sus d’innovation et lance un défi

Enfin, un dernier bloc d’étude se consacre à la réponse innovante des entre- prises face à des chocs externes (dérégula- tion, globalisation, financiarisation) et internes

Dans le cadre de cette recherche, nous allons nous focaliser sur l’application pharmaceutique de la biotechnologie et tenons à étudier le lien entre l’étendue de la

L’importance de la connaissance spécifique de l’industrie est généralement admise dans la littérature comme facteur de succès de la création d’entreprises, mais les

Caractéristiques de la réaction et performance du nouveau produit La réaction concurrentielle à l’introduction d’un nouveau produit est définie comme l’ensemble des

Le niveau d’analyse de la stratégie n’est plus l’environnement, mais la firme elle- même, ses ressources agglomérées en por- tefeuille de compétences, qui lui permettent

Les vertus de l’IS pour cette catégorie d’acteurs sont discutées à travers l’étude approfondie d’un cas : l’introduc- tion par Pathé (suivi d’UGC et Gaumont), à partir

plus loin les investigations sur cette méthode et d’analyser les différences entre entreprises de biotechnologie et groupes pharmaceutiques « traditionnels » telles